Eccentric muscle challenge shows osteopontin polymorphism modulation of muscle damage von Barfield, Whitney L, Uaesoontrachoon, Kitipong, Wu, Chung-Sheih, Lin, Stephen, Chen, Yue, Wang, Paul C, Kanaan, Yasmine, Bond, Vernon, Hoffman, Eric P

Volltext

Protease-activated receptors in the musculoskeletal system von Mackie, E.J., Loh, L.-H., Sivagurunathan, S., Uaesoontrachoon, K., Yoo, H.-J., Wong, D., Georgy, S.R., Pagel, C.N.

Volltext

290P Developing a non-invasive, in vivo method for evaluating muscle inflammation longitudinally in two mouse models of Duchenne muscular dystrophy von MacKinnon, A., Rowsell, J., Uaesoontrachoon, K., Mullen, A., Hoffman, E., Nagaraju, K.

Volltext

P.11.3 Long term treatment with naproxcinod significantly improves skeletal and cardiac function in mdx mouse model of dystrophy von Nagaraju, K, Uaesoontrachoon, K, Quinn, J, Tatem, K, Creeden, B, Vandermeulen, J, Yu, Q, Gordish, H, Ongini, E, Miglietta, D

Volltext

P32 Jak inhibitors Tofacitinib and Ruxolitinib do not improve functional deficits in dystrophin-deficient mdx mice von Bosco, C., Uaesoontrachoon, K., Srinivassane, S., Rowsell, J., Elustondo, P., Mackinnon, A., Nagaraju, K., Peterson, J.

Volltext

DMD – ANIMAL MODELS & PRECLINICAL TREATMENT von Gordish-Dressman, H., Uaesoontrachoon, K., Mackinnon, A., Mullen, A., Hoffman, E., Nagaraju, K.

Volltext

DMD – ANIMAL MODELS & PRECLINICAL TREATMENT: P.217 Enhancing the rigor and reproducibility of preclinical efficacy drug trials for DMD using reduced number of wild type and mdx con... von Gordish-Dressman, H., Uaesoontrachoon, K., Mackinnon, A., Mullen, A., Hoffman, E., Nagaraju, K.

Volltext

Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy von Uaesoontrachoon, Kitipong, Quinn, James L, Tatem, Kathleen S, Van Der Meulen, Jack H, Yu, Qing, Phadke, Aditi, Miller, Brittany K, Gordish-Dressman, Heather, Ongini, Ennio, Miglietta, Daniela, Nagaraju, Kanneboyina

Volltext

P.309 - Success of preclinical drug trials using reliable and reproducible endpoints in mouse models of neuromuscular diseases von Nagaraju, K., Mullen, A., MacKinnon, A., Uaesoontrachoon, K., Hoffman, E., Srinivassane, S.

Volltext

Success of preclinical drug trials using reliable and reproducible endpoints in mouse models of neuromuscular diseases von Nagaraju, K., Mullen, A., MacKinnon, A., Uaesoontrachoon, K., Hoffman, E., Srinivassane, S.

Volltext

VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice von Damsker, Jesse M, Dillingham, Blythe C, Rose, Mary C, Balsley, Molly A, Heier, Christopher R, Watson, Alan M, Stemmy, Erik J, Jurjus, Roslyn A, Huynh, Tony, Tatem, Kathleen, Uaesoontrachoon, Kitipong, Berry, Dana M, Benton, Angela S, Freishtat, Robert J, Hoffman, Eric P, McCall, John M, Gordish-Dressman, Heather, Constant, Stephanie L, Reeves, Erica K M, Nagaraju, Kanneboyina

Volltext

REGISTRIES AND CARE OF NEUROMUSCULAR DISORDERS: P.297Treatment responsive outcome measures in mouse models of neuromuscular disease von Mullen, A., Uaesoontrachoon, K., Srinivassane, S., Moraca, M., Ross, W., MacKinnon, A., Bell, C., Gillis, E., Rowsell, J., Malbasic, M., Barkhouse, M., Warford, J., Shala, D., Hoffman, E., Nagaraju, K.

Volltext

REGISTRIES AND CARE OF NEUROMUSCULAR DISORDERS von Mullen, A., Uaesoontrachoon, K., Srinivassane, S., Moraca, M., Ross, W., MacKinnon, A., Bell, C., Gillis, E., Rowsell, J., Malbasic, M., Barkhouse, M., Warford, J., Shala, D., Hoffman, E., Nagaraju, K.

Volltext

Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy von Yu, Qing, Sali, Arpana, Van der Meulen, Jack, Creeden, Brittany K, Gordish-Dressman, Heather, Rutkowski, Anne, Rayavarapu, Sree, Uaesoontrachoon, Kitipong, Huynh, Tony, Nagaraju, Kanneboyina, Spurney, Christopher F

Volltext

Osteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a mouse model of muscle injury von Uaesoontrachoon, Kitipong, Wasgewatte Wijesinghe, Dimuthu K, Mackie, Eleanor J, Pagel, Charles N

Volltext

Mitochondrial dysfunction and consequences in calpain-3-deficient muscle von Jahnke, Vanessa E, Peterson, Jennifer M, Van Der Meulen, Jack H, Boehler, Jessica, Uaesoontrachoon, Kitipong, Johnston, Helen K, Defour, Aurelia, Phadke, Aditi, Yu, Qing, Jaiswal, Jyoti K, Nagaraju, Kanneboyina

Volltext

Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy2J Mouse Model of Congenital Muscular Dystrophy von Yu, Qing, Sali, Arpana, Van der Meulen, Jack, Creeden, Brittany K., Gordish-Dressman, Heather, Rutkowski, Anne, Rayavarapu, Sree, Uaesoontrachoon, Kitipong, Huynh, Tony, Nagaraju, Kanneboyina, Spurney, Christopher F.

Volltext

Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy.sup.2J Mouse Model of Congenital Muscular Dystrophy von Yu, Qing, Sali, Arpana, Van der Meulen, Jack, Creeden, Brittany K, Gordish-Dressman, Heather, Rutkowski, Anne, Rayavarapu, Sree, Uaesoontrachoon, Kitipong, Huynh, Tony, Nagaraju, Kanneboyina, Spurney, Christopher F

Volltext

Osteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a model of muscle injury von Uaesoontrachoon, Kitipong, Wasgewatte Wijesinghe, Dimuthu K., Mackie, Eleanor J., Pagel, Charles N.

Volltext

Additional file 2 of Mitochondrial dysfunction and consequences in calpain-3-deficient muscle von Jahnke, Vanessa E., Peterson, Jennifer M., Van Der Meulen, Jack H., Boehler, Jessica, Uaesoontrachoon, Kitipong, Johnston, Helen K., Defour, Aurelia, Phadke, Aditi, Yu, Qing, Jaiswal, Jyoti K., Nagaraju, Kanneboyina

Volltext bestellen